Intelligence · Patents
Patents expiring in 2040
Annual patent cliff calendar for 2040 — US pharmaceutical patents by expiration date.
- Patents
- 1,866
Quick answer
1,866 indexed pharmaceutical patents have expiration dates in 2040. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 10716854
Stable aqueous formulations of adalimumab
granted -
US 10716851
Agonist antibodies that bind human CD137 and uses thereof
granted -
US 10716843
Immune enhancing recombinant dengue protein
granted -
US 10716853
Stable aqueous formulations of adalimumab
granted -
US 10716852
Stable aqueous formulations of adalimumab
granted -
US 10716808
Methods and compositions to modulate hair growth
granted -
US 10716782
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted -
US 10716793
Treprostinil administration by inhalation
granted -
US 10716798
Compositions and methods for tranquilizing heart muscle
granted -
US 10716758
Liposomal statin formulation
granted -
US 10717720
Modified compound of andrographolide
granted -
US 10722523
Chemoimmunotherapy for epithelial cancer
granted -
US 10722504
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 10722525
Targeted therapeutics
granted -
US 10722537
Activation of resident memory T cells for cancer immunotherapy
granted -
US 10722540
Microfluidic device and method for shear stress-induced transformation of cells
granted -
US 10722550
Compositions and methods for the treatment of fungal infections
granted -
US 10722573
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted -
US 10722579
Stable aqueous formulations of adalimumab
granted -
US 10722581
Phonophoretic cannabidiol composition and transdermal delivery system
granted -
US 10722583
Pharmaceutical compositions comprising meloxicam
granted -
US 10722561
Aquaporin 2 protects cattle from ticks and tick-borne parasites
granted -
US 10723737
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
granted -
US 10723702
Photocrosslinking reagents and methods of use thereof
granted -
US 10722499
Anyhydrous compositions of mTOR inhibitors and methods of use
granted -
US 10722478
Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
granted -
US 10722475
Stealth nanocapsules for protein delivery
granted -
US 10724007
Development of dengue virus vaccine components
granted -
US 10723803
CD47 targeted therapies for the treatment of infectious disease
granted -
US 10723777
Peptide having anti-obesity and anti-diabetes efficacy and use thereof
granted -
US 10723780
Synthetic somatostatin receptor ligands
granted -
US 10723785
Serpin fusion polypeptides and methods of use thereof
granted -
US 10723787
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
granted -
US 10723778
Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
granted -
US 10723733
Hepatitis B antiviral agents
granted -
US 10723784
Compositions and methods for preparing a subject for organ or non-organ implantation
granted -
US 10723857
Polyimide aerogels with reduced shrinkage from isothermal aging
granted -
US 10723741
DNA polymerase IIIC inhibitors and use thereof
granted -
US 10723759
Inhibitors of glucocorticoid receptor
granted -
US 10723764
Anti-microbial peptides and methods of use thereof
granted -
US 10722459
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
granted -
US 10724026
Engineered primate L-methioninase for therapeutic purposes
granted -
US 10722487
Glutaminase inhibitor therapy
granted -
US 10724020
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 10723718
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted -
US 10722594
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
granted -
US 2020239601
CROSSLINKED POLYMERIC NETWORK AND USE THEREOF
granted -
US 10730925
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
granted
Frequently asked questions
How many pharma patents expire in 2040?
1,866 published patents in our USPTO index have expiration dates falling in calendar year 2040.